For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB ...

A new study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them. A University of Otago-led study has found highly vulnerable weakness ...

The spread of multi-drug resistant TB is a growing global health problem, not just in the least developed nations, but also in developed countries, where the disease is staging a comeback.

Drug-resistant tuberculosis (TB) is a major contributor to global antimicrobial resistance with around half a million people falling ill with drug-resistant strains annually. Mycobacterium ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug ...

A new antibiotic for tuberculosis (TB) targets multidrug-resistant strains, paving the way for advanced treatments and innovative drug development, according to Rutgers Health research.